CHIP May Affect Some Outcomes in Patients Receiving CAR T-Cell Therapy
CHIP was associated with higher rates of complete response and cytokine release syndrome.
Lymphoma
Waldenström Macroglobulinemia/ Lymphoplasmacytic Lymphoma Treatment Regimens
View treatment regimens for Waldenstrom’s Macroglobulinemia/Lymphoplasmacytic Lymphoma, including combination therapies with bortezomib and more.
Treatment Impacts on Fertility for Patients With Hodgkin Lymphoma or Diffuse Large B-Cell Lymphoma
Researchers sought to determine the fertility-related issues and approaches for survivors of Hodgkin lymphoma and diffuse large B-cell lymphoma.
Baseline SUVmax May Have Prognostic Value in Patients With Follicular Lymphoma
Researchers sought to determine whether baseline SUVmax would have prognostic value in patients with follicular lymphoma.
ASCT-Related Symptoms Influence Quality of Life for Patients With Lymphoma, Myeloma
Study sought to determine the effect of symptoms on HRQOL in patients with myeloma or lymphoma undergoing autologous stem cell transplantation.
Rituximab Maintenance Prolongs Survival for Older Patients With Mantle Cell Lymphoma
Rituximab maintenance was significantly associated with improved overall survival in younger and older patients.
CNS Involvement Confers Poor Prognosis in Burkitt Lymphoma Regardless of First-Line Treatment
CNS involvement was an independent predictor of progression-free and overall survival.
Primary Central Nervous System Lymphoma May Be Treated by Methotrexate Outside Clinical Trials
Researchers sought to determine whether patients with PCNSL who are not eligible for clinical trials may benefit from high-dose methotrexate.
Brentuximab Vedotin May Improve Outcomes in Anaplastic Large Cell Lymphoma
Researchers sought to determine whether adding brentuximab vedotin to chemotherapy would be safe and effective in pediatric patients with ALCL.
Risk of Cardiovascular Death in Patients With Primary Central Nervous System Lymphoma
Risk of CVD death is lower with PCNSL than with extra-central nervous system lymphoma; however, the risk with this rare non-Hodgkin lymphoma is uncertain.
- Loading...
Loading...
Loading... 
Loading...